Profil

Martinive Philippe

Département des sciences biomédicales et précliniques

See author's contact details
Main Referenced Co-authors
Coucke, Philippe  (40)
Lallemand, François  (25)
Leroi, Natacha  (23)
Noël, Agnès  (19)
Bahri, Mohamed Ali  (11)
Main Referenced Keywords
radiotherapy (15); MRI (6); Radiotherapy (5); Radiothérapie (5); angiogenesis (4);
Main Referenced Unit & Research Centers
GIGA CRC (Cyclotron Research Center) In vivo Imaging-Aging & Memory - ULiège [BE] (8)
Giga Neurosciences - ULiège [BE] (1)
Laboratoire d'étude des tumeurs et du developpement (1)
Laboratoire de Biologie des Tumeurs et Développement (1)
Laboratoire de recherche sur les métastases (1)
Main Referenced Disciplines
Oncology (61)
Radiology, nuclear medicine & imaging (18)
Veterinary medicine & animal health (5)
Gastroenterology & hepatology (4)
Computer science (3)

Publications (total 78)

The most downloaded
3843 downloads
MARTINIVE, P., VAN DAELE, D., LENNERTS, E., ALLEPAERTS, S., POLUS, M., COIMBRA MARQUES, C., KOHNEN, L., VANDERICK, J., COLLIGNON, J., & COUCKE, P. (2014). LA RADIOTHÉRAPIE DANS LE CANCER DU RECTUM : quand, comment et pourquoi ? Revue Médicale de Liège, 69 (Supp 1), 37-46. https://hdl.handle.net/2268/164040

The most cited

166 citations (Scopus®)

Martinive, P., DEFRESNE, F., BOUZIN, C., SALIEZ, J., LAIR, F., GREGOIRE, V., MICHIELS, C., DESSY, C., & FERON, O. (15 December 2006). Preconditioning of the Tumor Vasculature and Tumor Cells by Intermittent Hypoxia: Implications for Anticancer Therapies. Cancer Research, 66 (24), 11736-44. doi:10.1158/0008-5472.CAN-06-2056 https://hdl.handle.net/2268/17883

Donis, N., Jiang, Z., D'Emal, C., Hulin, A., Debuisson, M., Dulgheru, R. E., Nguyen, M.-L., Postolache, A., LALLEMAND, F., COUCKE, P., Martinive, P., Herzog, M., Pamart, D., Terrell, J., Pincemail, J., Drion, P., DELVENNE, P., Nchimi Longang, A., LANCELLOTTI, P., & Oury, C. (28 February 2022). Differential Biological Effects of Dietary Lipids and Irradiation on the Aorta, Aortic Valve, and the Mitral Valve. Frontiers in Cardiovascular Medicine, 9, 1-16. doi:10.3389/fcvm.2022.839720
Peer Reviewed verified by ORBi

LALLEMAND, F., LEROI, N., Blacher, S., Bahri, M. A., Balteau, E., COUCKE, P., Noël, A., Plenevaux, A., & Martinive, P. (2021). Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study. Frontiers in Oncology. doi:10.3389/fonc.2021.784437
Peer Reviewed verified by ORBi

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2019). Tumor modifications recorded with IVIM and DCE-MRI after Neoadjuvant radiotherapy. Radiotherapy and Oncology, 133 (Supplement 1), 284 - S285. doi:10.1016/S0167-8140(19)30960-0
Peer Reviewed verified by ORBi

Rolot, M., Dougall, A., Javaux, J., Lallemand, F., Machiels, B., Martinive, P., Gillet, L., & Dewals, B. G. (2019). Recruitment of hepatic macrophages from monocytes is independent of IL-4Ralpha but is associated with ablation of resident macrophages in schistosomiasis. European Journal of Immunology. doi:10.1002/eji.201847796
Peer Reviewed verified by ORBi

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2018). Brain modifications after stereotactic radiotherapy recorded by Functional MRI. Radiotherapy and Oncology, 127 (Supplement 1), 582. doi:10.1016/S0167-8140(18)31346-X
Peer Reviewed verified by ORBi

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2018). Tumor microenvironment modifications recorded with IVIM perfusion analysis after radiotherapy. Radiotherapy and Oncology, 127 (Supplement 1), 1285-S1286. doi:10.1016/S0167-8140(18)32640-9
Peer Reviewed verified by ORBi

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., Plenevaux, A., & Martinive, P. (14 March 2018). Evaluation of tumor perfusion with IVIM analysis after radiotherapy [Paper presentation]. Fourth Symposium on small animal precision image-guided radiotherapy, Lisbonne, Portugal.

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., Plenevaux, A., & Martinive, P. (12 March 2018). Brain stereotactic radiotherapy damages recorded by Functional MRI [Poster presentation]. Fourth Symposium on small animal precision image-guided radiotherapy, Lisbonne, Portugal.

Machiels, B., Dourcy, M., Xiao, X., Javaux, J., Mesnil, C., Sabatel, C., Desmecht, D., LALLEMAND, F., Martinive, P., Hammad, H., Guilliams, M., Dewals, B., Vanderplasschen, A., Lambrecht, B. N., Bureau, F., & Gillet, L. (2018). Correction to: A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes (Nature Immunology, (2017), 18, 12, (1310-1320), 10.1038/ni.3857). Nature Immunology, 19 (9), 1035. doi:10.1038/s41590-017-0024-8
Peer Reviewed verified by ORBi

LOVINFOSSE, P., POLUS, M., VAN DAELE, D., Martinive, P., DAENEN, F., Hatt, M., Visvikis, D., KOOPMANSCH, B., LAMBERT, F., COIMBRA MARQUES, C., SEIDEL, L., Albert, A., Delvenne, P., & Hustinx, R. (2018). FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-017-3855-5
Peer Reviewed verified by ORBi

Vandaele, R., Aceto, J., Muller, M., Peronnet, F., Debat, V., Wang, C.-W., Huang, C.-T., Jodogne, S., Martinive, P., Geurts, P., & Marée, R. (2018). Landmark detection in 2D bioimages for geometric morphometrics: a multi-resolution tree-based approach. Scientific Reports, 8 (1), 538. doi:10.1038/s41598-017-18993-5
Peer Reviewed verified by ORBi

Machiels, B., Dourcy, M., Xiao, X., Javaux, J., Mesnil, C., Sabatel, C., Desmecht, D., Lallemand, F., Martinive, P., Hammad, H., Guilliams, M., Dewals, B. G., Vanderplasschen, A., Lambrecht, B. N., Bureau, F., & Gillet, L. (December 2017). A gammaherpesviru provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes [Paper presentation]. Belgian Society for Virology.
Peer reviewed

Machiels, B., Dourcy, M., Xiao, X., Javaux, J., Mesnil, C., Sabatel, C., Desmecht, D., Lallemand, F., Martinive, P., Hammad, H., Guilliams, M., Dewals, B. G., Vanderplasschen, A., Lambrecht, B., Bureau, F., & Gillet, L. (October 2017). A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes [Paper presentation]. Farah Day 2017.
Peer reviewed

Machiels, B., Dourcy, M., Xiao, X., Javaux, J., Mesnil, C., Sabatel, C., Desmecht, D., Lallemand, F., Martinive, P., Hammad, H., Guilliams, M., Dewals, B. G., Vanderplasschen, A., Lambrecht, B., Bureau, F., & Gillet, L. (July 2017). A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes [Paper presentation]. International Herpesvirus Workshop.
Peer reviewed

Machiels, B., Dourcy, M., Xiao, X., Mesnil, C., Sabatel, C., Desmecht, D., Lallemand, F., Martinive, P., Hammad, H., Guilliams, M., Dewals, B. G., Vanderplasschen, A., Lambrecht, B., Bureau, F., & Gillet, L. (May 2017). A gammaherpesvirus infection protects against allergic asthma through the replacement of resident alveolar macrophages by regulatory monocytes [Paper presentation]. Immunology Day - FNRS immunology doctoral school.
Peer reviewed

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (May 2017). Following tumour microenvironment after Neoadjuvant radiotherapy with IVIM perfusion analysis. Radiotherapy and Oncology, 123 (Supplement 1), 545. doi:10.1016/S0167-8140(17)31424-X
Peer Reviewed verified by ORBi

Berkovic, P., GULYBAN, A., Nguyen, P. V., DECHAMBRE, D., Martinive, P., JANSEN, N., Lakosi, F., Janvary, L., & Coucke, P. (20 March 2017). Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence. Clinical Colorectal Cancer, 16 (4), 349-357.e1. doi:10.1016/j.clcc.2017.03.006
Peer Reviewed verified by ORBi

VAN DAELE, D., Honoré, P., COLLIGNON, J., POLUS, M., LOLY, C., MUTIJIMA NZARAMBA, E., De Roover, A., Coucke, P., Louis, E., & Martinive, P. (2017). Comment je traite... les cancers localises de l'oesophage. Etat actuel des donnees et strategie therapeutique. 2eme partie : l'interet des approches multimodales avec ou sans chirurgie. Revue Médicale de Liège, 72 (4), 168-174.
Peer reviewed

Machiels, B., Dourcy, M., Xiao, X., Javaux, J., Mesnil, C., Sabatel, C., Desmecht, D., Lallemand, F., Martinive, P., Hammad, H., Guilliams, M., Dewals, B. G., Vanderplasschen, A., Lambrecht, B. N., Bureau, F., & Gillet, L. (2017). A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes. Nature Immunology. doi:10.1038/ni.3857
Peer Reviewed verified by ORBi

Vandaele, R., LALLEMAND, F., MARTINIVE, P., GULYBAN, A., JODOGNE, S., COUCKE, P., Geurts, P., & Marée, R. (2017). Automated multimodal volume registration based on supervised 3D anatomical landmark detection. In SCITEPRESS Digital Library.
Peer reviewed

VAN DAELE, D., Honoré, P., COLLIGNON, J., POLUS, M., LOLY, C., MUTIJIMA NZARAMBA, E., De Roover, A., Coucke, P., Louis, E., & Martinive, P. (2017). Comment je traite... les cancers localises de l'oesophage. Etat actuel des donnees et strategie therapeutique. 1ere partie : le point sur les approches chirurgicales et non chirurgicales. Revue Médicale de Liège, 72 (2), 58-63.
Peer reviewed

Goffart, N.* , LOMBARD, A.* , Lallemand, F., Kroonen, J., Nassen, J., Di Valentin, E., Berendsen, S., Dedobbeleer, M., Willems, E., Robe, P., Bours, V., Martin, D., Martinive, P., Maquet, P., & Rogister, B. (2017). CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone. Neuro-Oncology, 19 (1), 66-77. doi:10.1093/neuonc/now136
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Henry, A., Nokin, M.-J., Leroi, N., Lallemand, F., Lambert, J., Goffart, N., RONCARATI, P., BIANCHI, E., Peixoto, P., Blomme, A., Turtoi, A., Peulen, O., Habraken, Y., Scholtes, F., Martinive, P., Delvenne, P., Rogister, B., Castronovo, V., & Bellahcene, A. (2016). New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity. Oncotarget. doi:10.18632/oncotarget.11483
Peer Reviewed verified by ORBi

Leroi, N., LALLEMAND, F., COUCKE, P., Noël, A., & MARTINIVE, P. (30 March 2016). Impacts of Ionizing Radiation on the Different Compartments of the Tumor Microenvironment. Frontiers in Pharmacology, 7, 1-9. doi:10.3389/fphar.2016.00078
Peer Reviewed verified by ORBi

LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., Plenevaux, A., & MARTINIVE, P. (22 March 2016). Feasibility study of repetitive diffusion MRI after Neoadjuvant radiotherapy for following tumor microenvironment [Paper presentation]. 3rd Symposium on small animal precision image-guided radiotherapy, Gend, Belgium.

Henry, A., Nokin, M.-J., Leroi, N., LALLEMAND, F., Lambert, J., Goffart, N., Peixoto, P., Blomme, A., BIANCHI, E., Habraken, Y., RONCARATI, P., Peulen, O., SCHOLTES, F., MARTINIVE, P., Rogister, B., Delvenne, P., Turtoi, A., Castronovo, V., & Bellahcene, A. (22 March 2016). Osteopontin predicts radiotherapy response of glioblastoma patients : new role in DNA damage repair [Paper presentation]. 3rd Symposium on small animal precision image-guided radiotherapy, Gand, Belgium.

Leroi, N., BLACHER, S., Lallemand, F., Leenders, J., De Tullio, P., COUCKE, P., Noël, A., & MARTINIVE, P. (30 January 2016). Metabolomic analyzes of the tumor microenvironment after neoadjuvant radiotherapy implicated in surgery-related metastatic spreading [Paper presentation]. BACR, Bruxelles, Belgium.

LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., MARTINIVE, P., & Plenevaux, A. (2016). Diffusion MRI for following tumor modifications after neoadjuvant radiotherapy. Radiotherapy and Oncology, 119, 966-S967.
Peer Reviewed verified by ORBi

WITHOFS, N., Martinive, P., VANDERICK, J., BLETARD, N., SCAGNOL, I., Mievis, F., Giacomelli, F., Coucke, P., Delvenne, P., Cataldo, D., Gambhir, S. S., & HUSTINX, R. (2016). [18F]FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-015-3219-y
Peer Reviewed verified by ORBi

Henry, A., Bellahcene, A., Castronovo, V., Peixoto, P., Goffart, N., Lallemand, F., Leroi, N., Peulen, O., MARTINIVE, P., Habraken, Y., Turtoi, A., Rogister, B., & Blomme, A. (Other coll.). (10 September 2015). Osteopontin as a new target in glioblastoma progression and resistance to radiotherapy [Paper presentation]. II International Symposium on clinical and basic investigation in glioblastoma, Toledo, Spain.

Vandaele, R., Marée, R., COUCKE, P., GULYBAN, A., LALLEMAND, F., Geurts, P., JODOGNE, S., & MARTINIVE, P. (April 2015). Automated Landmark Detection For Rigid Registration Between The Simulation-CT and the Treatment CBCT [Poster presentation]. 3rd ESTRO FORUM, Barcelone, Spain.

LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., MARTINIVE, P., & Plenevaux, A. (April 2015). Functional MRI for predicting metastatic spreading at the time of surgery after neoadjuvant radiotherapy. Radiotherapy and Oncology, 115 (Supplement 1), 832-S833. doi:10.1016/S0167-8140(15)41518-X
Peer Reviewed verified by ORBi

LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., MARTINIVE, P., & Plenevaux, A. (27 January 2015). Identification of predictive markers based on functional imaging of metastatic spreading at the time of surgery after neoadjuvant radiotherapy [Poster presentation]. Giga day 2015, Liège, Belgium.

VAN DAELE, D., Martinive, P., LOLY, C., POLUS, M., COLLIGNON, J., GAST, P., Louis, E., & Van Laethem, J.-L. (2015). COMMENT JE TRAITE ... Point de vue critique sur l'approche actuelle du cancer du pancreas localisé. Revue Médicale de Liège, 70 (11), 540-5.
Peer reviewed

Goffart, N., KROONEN, J., Di Valentin, E., Dedobbeleer, M., Denne, A., Martinive, P., & Rogister, B. (2015). Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12/CXCR4 signaling. Neuro-Oncology, 17 (1), 81-94. doi:10.1093/neuonc/nou144
Peer Reviewed verified by ORBi

Leroi, N., Sounni, N. E., Van Overmeire, E., Blacher, S., Marée, R., Van Ginderachter, J., Lallemand, F., LENAERTS, E., COUCKE, P., Noël, A.* , & MARTINIVE, P.*. (2015). The timing of surgery after neoadjuvant radiotherapy influences tumor dissemination in a preclinical model. Oncotarget. doi:10.18632/oncotarget.5931
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

VAN DAELE, D., Puleo, F., Dumont, R., POLUS, M., Loly, C., Martinive, P., Meunier, P., Collignon, J., Hendlisz, A., Marechal, R., Louis, E., & Van Laethem, J.-L. (2015). Evolution dans la prise en charge de l'adenocarcinome du pancreas localise estime resecable. Revue Médicale Suisse, 11 (483), 1543-8.
Peer Reviewed verified by ORBi

Leroi, N., Blacher, S., Marée, R., Noël, A., COUCKE, P., & MARTINIVE, P. (29 June 2014). Does neoadjuvant radiotherapy and the timing of surgery modify metastatic dissemination? [Paper presentation]. 15th International Biennial Congress of the Metastasis Research Society, Heidelberg, Germany.

MARTINIVE, P., VAN DAELE, D., LENNERTS, E., ALLEPAERTS, S., POLUS, M., COIMBRA MARQUES, C., KOHNEN, L., VANDERICK, J., COLLIGNON, J., & COUCKE, P. (2014). LA RADIOTHÉRAPIE DANS LE CANCER DU RECTUM : quand, comment et pourquoi ? Revue Médicale de Liège, 69 (Supp 1), 37-46.
Peer reviewed

WITHOFS, N., BERNARD, C., VAN DER REST, C., MARTINIVE, P., HATT, M., JODOGNE, S., VISVIKIS, D., LEE, J. A., COUCKE, P., & HUSTINX, R. (2014). FDG PET/CT for rectal carcinoma radiotherapy treatment planning : Comparison of functional volume delineation algorithms and clinical challenges. Journal of Applied Clinical Medical Physics, 15 (5), 216-228. doi:10.1120/jacmp.v15i5.4696
Peer Reviewed verified by ORBi

LALLEMAND, F., LAKOSI, F., HUSTINX, R., WITHOFS, N., MEUNIER, P., TSHIBANDA, L., JODOGNE, S., COUCKE, P., & MARTINIVE, P. (2014). Utilisation de l'imagerie fonctionnelle en radiothérapie. Revue Médicale de Liège, 69 (Supp 1), 20-28.
Peer reviewed

COUCKE, P., & MARTINIVE, P. (2014). LA RADIOBIOLOGIE POUR LES NÉOPHYTES. Revue Médicale de Liège, 69 (Supp 1), 16-19.
Peer reviewed

MARTINIVE, P., ALLEPAERTS, S., VAN DAELE, D., POLUS, M., COIMBRA MARQUES, C., KOHNEN, L., COLLIGNON, J., LENNERTS, E., VANDERICK, J., & COUCKE, P. (2014). LA RADIOTHÉRAPIE DANS LE CANCER DU RECTUM CHEZ LA PERSONNE ÂGÉE: Quel bénéfice pour le traitement ? Revue Médicale de Liège, 69 (Supp 1), 47-52.
Peer reviewed

Leroi, N., Blacher, S., Marée, R., Noël, A., COUCKE, P., & MARTINIVE, P. (2014). Influence of tumor inflammatory microenvironment after neoadjuvant radiotherapy on lung metastases occurrence in a mouse model [Paper presentation]. BACR, Gand, Belgium.

JODOGNE, S., SOBCZAK, S., DEVILLERS, M., LENAERTS, E., MARTINIVE, P., & COUCKE, P. (April 2013). Orthanc - Lightweight, Scriptable DICOM Server for Medical Image Management in Radiotherapy. Radiotherapy and Oncology, 106 (2), 488.
Peer Reviewed verified by ORBi

Leroi, N., NOEL, A., COUCKE, P., & MARTINIVE, P. (2013). Optimizing the timing of surgery after neoadjuvant radiotherapy for decreasing tumor metastasis [Paper presentation]. BACR, Anvers, Belgium.

Leroi, N., Noël, A., COUCKE, P., & MARTINIVE, P. (May 2012). Modeling neoadjuvant radiotherapy for improving treatments efficacy [Poster presentation]. ESTRO 31.

Leroi, N., COUCKE, P., Noël, A., & MARTINIVE, P. (February 2012). Tailoring the timing of surgery based on the neoadjuvant radiotherapy schedule for decreasing tumor dissemination at the time of surgical procedure [Paper presentation]. International Conference on Transnational Research in Radiation Oncology, Genève, Switzerland.

WITHOFS, N., MARTINIVE, P., SCAGNOL, I., THONON, D., Giacomelli, F., Mievis, F., COUCKE, P., CATALDO, D., Gambhir, S., & HUSTINX, R. (2012). Preliminary results of (18F)FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma. Journal of Nuclear Medicine, 53 (SUPPL), 1703.
Peer Reviewed verified by ORBi

WITHOFS, N., Bernard, C., VAN DER REST, C., MARTINIVE, P., HATT, M., Dimitris, V., COUCKE, P., & HUSTINX, R. (2011). FDG PET/CT for radiotherapy treatment planning. Comparison of functional volume delineation algorithms. Journal of Nuclear Medicine.
Peer reviewed

JANVARY, Z. L., JANSEN, N., MARTINIVE, P., & COUCKE, P. (2011). New indications for radiotherapy: primary liver cancer and secondary liver oligometastases. Belgian Journal of Medical Oncology, 5 (1), 8-13.
Peer Reviewed verified by ORBi

Leroi, N., boujouf, S., COUCKE, P., Noël, A., & MARTINIVE, P. (January 2011). does neoadjuvant radiotherapy promote tumor dissemination [Poster presentation]. BACR-ABEC-BVSK.

JANVARY, Z. L., JANSEN, N., MATHOT, M., LENAERTS, E., MARTINIVE, P., & COUCKE, P. (September 2010). EVALUATION OF THE AUTOMATIC IMAGE REGISTRATION FEATURES OF A KV CONE-BEAM CT IMAGING SYSTEM [Poster presentation]. Congrès.

JANVARY, Z. L., JANSEN, N., MATHOT, M., LENAERTS, E., MARTINIVE, P., & COUCKE, P. (September 2010). EVALUATION OF THE AUTOMATIC IMAGE REGISTRATION FEATURES OF A KV CONE-BEAM CT IMAGING SYSTEM. Radiotherapy and Oncology, 96 (supp 1).
Peer Reviewed verified by ORBi

JANVARY, Z. L., Broens, A., MARTINIVE, P., Vvavassis, P., Fieuw, J., LENAERTS, E., & COUCKE, P. (September 2010). 4DCT EVALUATION OF THE RESPIRATORY-RELATED MOVEMENT OF THE BREAST USING SURGICAL CLIPS AS FIDUCIALS [Poster presentation]. ESTRO.

Daneau, G., Boidot, R., MARTINIVE, P., & Feron, O. (15 January 2010). Identification of cyclooxygenase-2 as a major actor of the transcriptomic adaptation of endothelial and tumor cells to cyclic hypoxia: effect on angiogenesis and metastases. Clinical Cancer Research, 16 (2), 410-419. doi:10.1158/1078-0432.CCR-09-0583
Peer Reviewed verified by ORBi

MARTINIVE, P., & COUCKE, P. (2010). La vascularisation tumorale en tant que source de résistance aux traitements de radiothérapie et chimiothérapie. Revue Médicale de Liège, 65 (3), 133-139.
Peer reviewed

Martinive, P. (2008). Impact of cyclic hypoxia on HIF-1a regulation in endothelial cells: new insights for anti-tumor treatments. FEBS Journal. doi:10.1111/j.1742-4658.2008.06798.x
Peer Reviewed verified by ORBi

Cron, G. O., Ansiaux, MARTINIVE, P., Feron, O., Gallez, B., & Beghein, N. (Other coll.). (2008). (19) F NMR in vivo spectroscopy reflects the effectiveness of perfusion - enhancing vascular modifiers for improving gemcitabine chemotheraypy. Magnetic Resonance in Medicine. doi:10.1002/mrm.21469
Peer Reviewed verified by ORBi

Martinive, P. (January 2007). Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anti-cancer therapies [Poster presentation]. Meeting Gand, Gand, Belgium.

Martinive, P. (2007). Impact of oxygen and blood flow heterogeneities in tumors : new insights for anti-cancer and anti-angiogenic therapies [Doctoral thesis, UCL - Université Catholique de Louvain]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/17876

Crokart, N., JORDAN, B., BAUDELET, C., CRON, G., HOTTON, J., RADERMACHER, K., GREGOIRE, V., BEGHIN, N., MARTINIVE, P., BOUZIN, C., FERON, O., & GALLEZ, B. (2007). Glucocorticoids Modulate Tumor Radiation Response through a Decrease in Tumor Oxygen Consumption. Clinical Cancer Research, 15 (13), 630/5. doi:10.1158/1078-0432.CCR-06-0802
Peer Reviewed verified by ORBi

Martinive, P., DEFRESNE, F., BOUZIN, C., SALIEZ, J., LAIR, F., GREGOIRE, V., MICHIELS, C., DESSY, C., & FERON, O. (15 December 2006). Preconditioning of the Tumor Vasculature and Tumor Cells by Intermittent Hypoxia: Implications for Anticancer Therapies. Cancer Research, 66 (24), 11736-44. doi:10.1158/0008-5472.CAN-06-2056
Peer Reviewed verified by ORBi

SEGERS, J., DI FAZIO, V., ANSIAUX, R., MARTINIVE, P., FERON, O., Wallemacq, P., & GALLEZ, B. (28 November 2006). Potentiation of cyclophosphamide chemotherapy using the anti-angiogenic drug thalidomide: Importance of optimal scheduling to exploit the ‘normalization’ window of the tumor vasculature. Cancer Letters, 244 (1), 129/35. doi:10.1016/j.canlet.2005.12.017
Peer Reviewed verified by ORBi

ANSIAUX, R., BAUDELET, C., JORDAN, B., CROKART, N., DEWEVER, J., MARTINIVE, P., GREGOIRE, V., FERON, O., & GALLEZ. (01 October 2006). Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy. Cancer Research, 66 (19), 9698/704. doi:10.1158/0008-5472.CAN-06-1854
Peer Reviewed verified by ORBi

Martinive, P., DE WEVER, J., BOUZIN, C., BAUDELET, C., ONVEAUX, P., GREGOIRE, V., & FERON, O. (June 2006). Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable variable to improve drug delivery. Molecular Cancer Therapeutics, 5 (6), 1620/7. doi:10.1158/1535-7163.MCT-05-0472
Peer Reviewed verified by ORBi

SBAA, E., DE WEVER, J., MARTINIVE, P., BOUZIN, C., FRERART, F., BALLIGAND, J.-L., DESSY, C., & FERON, O. (12 May 2006). Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis. Circulation Research, 98 (9), 1219/27. doi:10.1161/01.RES.0000220648.80170.8b
Peer Reviewed verified by ORBi

Ansiaux, R., Baudelet, C., Cron, MARTINIVE, P., DEWEVER, J., GREGOIRE, V., FERON, O., & Gallez. (May 2006). Evolution of the tumor oxygenation and perfusion at the early stage of the treatment with SU5416, an inhibitor of Flk-1 tyrosine kinase [Poster presentation]. Proc. Intl. Soc. Mag. Reson. Med.

Martinive, P. (2006). Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable parameter to improve drug delivrery [Paper presentation]. Meeting Brussels, Bruxelles, Belgium.

ANSIAUX, R., BAUDELET, C., CRON, G., SEGERS, J., DESSY, C., Martinive, P., DE WEVER, J., VERRAX, J., WAUTHIER, V., BEGHEIN, N., GREGOIRE, V., BUC CALDERON, P., FERON, O., & GALLEZ, B. (15 February 2006). Botulinum toxin potentiates cancer radiotherapy and chemotherapy. Clinical Cancer Research, 12 (4), 1276/83. doi:10.1158/1078-0432.CCR-05-1222
Peer Reviewed verified by ORBi

Brouet, A., DeWever, J., MARTINIVE, P., Havaux, X., Bouzin, C., Sonveaux, P., Feron, O., & Martinive, P. (Other coll.). (2005). Anti-tumor effect of caveolin gene delivery are mediated through the inhibition of the pro-angiogenic and vasodilatating effect of nitric oxide. FASEB Journal, 602-4.
Peer Reviewed verified by ORBi

ANSIAUX, R., BAUDELET, C., JORDAN, B., BEGHEIN, N., SONVEAUX, P., DE WEVER, J., MARTINIVE, P., GREGOIRE, V., FERON, O., & Gallez, B. (15 January 2005). Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. Clinical Cancer Research, 15 (11), 743-750.
Peer Reviewed verified by ORBi

Crokart, Jordan, Baudelet, C., Cron, Hotton, Radermacher, GREGOIRE, V., Beghein, MARTINIVE, P., FERON, O., & Gallez. (26 November 2004). Characterization of the tumor micro-environment after administration of glucocorticoids to understand their radiosensitization effect [Poster presentation]. 3rd one day symposium.

Martinive, P., Sonveaux, P., Brouet, A., & Feron, O. (September 2004). Intrinsic and irradiation-induced tumor selectivity of liposome-based gene therapy targeting Akt activation [Poster presentation]. Experimental and Molecular Therapeutics.

Martinive, P., Sonveaux, P., DeWever, J., Batova, Z., Daneau, G., Pelat, M., Ghisdal, P., Grégoire, V., Dessy, C., Balligand, J.-L., & Feron, O. (2004). caveolin-1 expression is critical for VEGF-induced inschemic hindlimb collateralization and NO-mediated angiogenisis. Circulation Research, (95 (2)), 154-61.
Peer Reviewed verified by ORBi

Sonveaux, P., Dessy, MARTINIVE, P., Havaux, X., Jordan, B., Gallez, B., Gregoire, V., Balligand, J.-L., & Feron, O. (May 2004). Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: implications for cancer treatment. Cancer Research, 1 (64), 3209-14. doi:10.1158/0008-5472.CAN-03-1291
Peer Reviewed verified by ORBi

Martinive, P. (January 2004). Targeting the vascular tone of microarterioles with an endothelin-1 (ET-1) antagonist selectively modulates tumor blood flow and promotes response to treatment [Poster presentation]. BACR, Liège, Belgium.

Martinive, P. (2003). Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable parameter to improve drug delivery [Poster presentation]. American Association for Cancer Research (AACR), 97th Annual Meeting, Washington DC, United States.

Contact ORBi